{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:50:47Z","timestamp":1780325447149,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.nut.2019.110594","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T01:55:50Z","timestamp":1569549350000},"page":"110594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["\u03b1-lipoic acid in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-2954","authenticated-orcid":false,"given":"Silvia","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Petramala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-0236","authenticated-orcid":false,"given":"Maurizio","family":"Muscaritoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Paola","family":"Mitterhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"D'Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ansuini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesarina","family":"Ramaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Galani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ida","family":"Amabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Molfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4397-0624","authenticated-orcid":false,"given":"Claudio","family":"Letizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2019.110594_bib0001","first-page":"327","article-title":"Molecular basis of autosomal dominant polycystic kidney disease","volume":"19","author":"Watnick","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0003","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000343281","article-title":"Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Helal","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0004","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ki.1990.330","article-title":"Renal structure and hypertension in autosomal dominant polycystic kidney disease","volume":"38","author":"Gabow","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.nut.2019.110594_bib0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.nephro.2016.12.005","article-title":"Quality of life in patients with autosomal dominant polycystic kidney disease","volume":"13","author":"Lecardeur","year":"2017","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nut.2019.110594_bib0006","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/ndt\/gfv299","article-title":"Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease","volume":"31","author":"Simms","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2019.110594_bib0007","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2019.110594_bib0008","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2011.00069","article-title":"Diabetes and alpha lipoic Acid","volume":"2","author":"Golbidi","year":"2011","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nut.2019.110594_bib0009","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.111.189456","article-title":"Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption","volume":"59","author":"Wray","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.nut.2019.110594_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1476-511X-10-217","article-title":"Effect of \u03b1-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance","volume":"10","author":"McNeilly","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.nut.2019.110594_bib0011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/CIRCULATIONAHA.107.725275","article-title":"Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E\/low-density lipoprotein receptor-deficient mice","volume":"117","author":"Zhang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2019.110594_bib0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lfs.2009.11.009","article-title":"Lipoic acid effects on established atherosclerosis","volume":"86","author":"Ying","year":"2010","journal-title":"Life Sci"},{"key":"10.1016\/j.nut.2019.110594_bib0013","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0899-9007(01)00658-X","article-title":"Molecular aspects of lipoic acid in the prevention of diabetes complications","volume":"17","author":"Packer","year":"2001","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2019.110594_bib0014","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00004872-200018050-00009","article-title":"Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats","volume":"18","author":"Vasdev","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.nut.2019.110594_bib0015","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/db08-0473","article-title":"Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance","volume":"58","author":"Padmalayam","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.nut.2019.110594_bib0016","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2013.03.020","article-title":"Glutathionylation of \u03b1-ketoglutarate dehydrogenase: the chemical nature and relative susceptibility of the cofactor lipoic acid to modification","volume":"61","author":"McLain","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nut.2019.110594_bib0017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nut.2019.110594_bib0018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0019","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.nut.2019.110594_bib0020","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jamainternmed.2014.2482","article-title":"Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study","volume":"174","author":"Rodriguez","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.nut.2019.110594_bib0021","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jclinepi.2007.01.011","article-title":"Ankle brachial index and intima media thickness predict cardiovascular events similarly and increased prediction when combined","volume":"60","author":"Price","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.nut.2019.110594_bib0022","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCULATIONAHA.105.579268","article-title":"A clinician's guide to tissue Doppler imaging","volume":"113","author":"Ho","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2019.110594_bib0023","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/0886022X.2014.982489","article-title":"Early markers of cardiovascular risk in chronic kidney disease","volume":"37","author":"Lai","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.nut.2019.110594_bib0024","first-page":"3","article-title":"Assessment of vascular disease using arterial flow mediated dilatation","volume":"58","author":"Patel","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.nut.2019.110594_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2019.110594_bib0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.nut.2019.110594_bib0027","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"10.1016\/j.nut.2019.110594_bib0028","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0005-7967(99)00068-6","article-title":"Use of the Beck Depression Inventory-II with depressed geriatric inpatients","volume":"38","author":"Steer","year":"2000","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.nut.2019.110594_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3634948","article-title":"Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders","volume":"2016","author":"Janus","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nut.2019.110594_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease","volume":"106","author":"Ginsberg","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nut.2019.110594_bib0031","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/imj.14039","article-title":"Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease","volume":"48","author":"Lai","year":"2018","journal-title":"Intern Med J"},{"key":"10.1016\/j.nut.2019.110594_bib0032","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ndt\/gfu044","article-title":"Metabolic abnormalities in autosomal dominant polycystic kidney disease","volume":"30","author":"Mao","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2019.110594_bib0033","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.ajkd.2005.03.003","article-title":"Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment","volume":"45","author":"Kraut","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nut.2019.110594_bib0034","first-page":"225","article-title":"The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease","volume":"39","author":"Cozlea","year":"2013","journal-title":"Curr Health Sci J"},{"key":"10.1016\/j.nut.2019.110594_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000488064","article-title":"Epicardial fat thickness in patients with autosomal dominant polycystic kidney disease","volume":"8","author":"Concistr\u00e8","year":"2018","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.nut.2019.110594_bib0036","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"JASN"},{"key":"10.1016\/j.nut.2019.110594_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","article-title":"Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease","volume":"6","author":"Menon","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0038","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ki.1991.87","article-title":"Cytokines in fluids from polycystic kidneys","volume":"39","author":"Gardner","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.nut.2019.110594_bib0039","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","article-title":"Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease","volume":"14","author":"Zheng","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000502999","article-title":"Rapid progression of autosomal dominant polycystic kidney disease: urinary biomarkers as predictors","volume":"50","author":"Messchendorp","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0041","article-title":"Oxidative stress and arterial dysfunction in peripheral artery disease","volume":"7","author":"Ismaeel","year":"2018","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.nut.2019.110594_bib0042","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd3403","article-title":"Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets","volume":"10","author":"Drummond","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nut.2019.110594_bib0043","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","article-title":"Endothelial NADPH oxidases: which NOX to target in vascular disease?","volume":"25","author":"Drummond","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.nut.2019.110594_bib0044","doi-asserted-by":"crossref","first-page":"E104","DOI":"10.1152\/ajpendo.91023.2008","article-title":"Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells","volume":"297","author":"Zhao","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nut.2019.110594_bib0045","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.RES.0000263381.83835.7b","article-title":"Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice","volume":"100","author":"Bendall","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.nut.2019.110594_bib0046","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cvr\/cvs026","article-title":"Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE\u207b\/\u207b mice","volume":"94","author":"Douglas","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nut.2019.110594_bib0047","first-page":"2132","article-title":"The effect of alpha lipoic acid on rat kidneys in methotrexate induced oxidative injury","volume":"19","author":"\u00c7ak\u0131r","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.nut.2019.110594_bib0048","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1081\/IPH-51755","article-title":"Effects of antioxidants coenzyme Q10 and lipoic acid on interleukin-1 beta-mediated inhibition of glucose-stimulated insulin release from cultured mouse pancreatic islets","volume":"27","author":"Schroeder","year":"2005","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.nut.2019.110594_bib0049","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10620-011-2012-4","article-title":"Alpha-lipoic acid prevents the induction of iNOS gene expression through destabilization of its mRNA in proinflammatory cytokine-stimulated hepatocytes","volume":"57","author":"Yamada","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.nut.2019.110594_bib0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","article-title":"Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis","volume":"168","author":"Ras","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nut.2019.110594_bib0051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","article-title":"Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?","volume":"57","author":"Green","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.nut.2019.110594_bib0052","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1681\/ASN.2013121314","article-title":"Endothelial cilia are essential for developmental vascular integrity in zebrafish","volume":"26","author":"Kallakuri","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0053","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/HYPERTENSIONAHA.115.05536","article-title":"Renal resistive index and mortality in chronic kidney disease","volume":"66","author":"Toledo","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.nut.2019.110594_bib0054","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11255-013-0528-6","article-title":"Renal resistive index as a marker of vascular damage in cardiovascular diseases","volume":"46","author":"Lubas","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0055","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1093\/ndt\/gfr116","article-title":"Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction","volume":"26","author":"Ennezat","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2019.110594_bib0056","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1159\/000486011","article-title":"Early markers of cardiovascular risk in autosomal dominant polycystic kidney disease","volume":"42","author":"Lai","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.nut.2019.110594_bib0057","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1291\/hypres.27.221","article-title":"Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease","volume":"27","author":"Ramunni","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.nut.2019.110594_bib0058","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3317\/jraas.2006.023","article-title":"Autosomal dominant polycystic kidney disease: role of the rennin\u2013angiotensin system in raised blood pressure in progression of renal and cardiovascular disease","volume":"7","author":"Lawson","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.nut.2019.110594_bib0059","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/ndt\/gfr597","article-title":"The association between plasma uric acid and renal function decline in a Chinese population-based cohort","volume":"27","author":"Zhang","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2019.110594_bib0060","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/ndt\/gfn621","article-title":"Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease","volume":"24","author":"Navaneethan","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nut.2019.110594_bib0061","first-page":"1010","article-title":"Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease\u2014preliminary data","volume":"18","author":"Lai","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.nut.2019.110594_bib0062","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2369-15-63","article-title":"Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease","volume":"15","author":"Han","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nut.2019.110594_bib0063","doi-asserted-by":"crossref","first-page":"e4175","DOI":"10.1097\/MD.0000000000004175","article-title":"Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease","volume":"95","author":"Lai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nut.2019.110594_bib0064","doi-asserted-by":"crossref","first-page":"e5191","DOI":"10.1097\/MD.0000000000005191","article-title":"Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy","volume":"95","author":"Lai","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900719301789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900719301789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:09:44Z","timestamp":1760270984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900719301789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":64,"alternative-id":["S0899900719301789"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2019.110594","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-lipoic acid in patients with autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2019.110594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110594"}}